1997
DOI: 10.1021/jo9702655
|View full text |Cite
|
Sign up to set email alerts
|

Practical, Stereoselective Synthesis of Palinavir, a Potent HIV Protease Inhibitor

Abstract: Palinavir is a potent peptidomimetic-based HIV protease inhibitor. We have developed a highly convergent and stereoselective synthesis which is amenable to the preparation of multikilogram quantities of this compound. The synthetic sequence proceeds in 24 distinct chemical steps (with several integrated, multistep operations) from commercially available starting materials. No chromatographies are required throughout the process, and the final product is purified by crystallization of its dihydrochloride salt t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
39
0

Year Published

2000
2000
2016
2016

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 74 publications
(39 citation statements)
references
References 44 publications
(35 reference statements)
0
39
0
Order By: Relevance
“…For example, cis-4-L-HyPip is a component of palinavir, an HIV protease inhibitor (11,12), and cis-5-hydroxy-L-pipecolic acid (cis-5-L-HyPip) is a precursor for the synthesis of the ␤-lactamase inhibitor MK-7655 (13). Thus, the development of processes for the industrial synthesis of HyPips may be of great significance.…”
mentioning
confidence: 99%
“…For example, cis-4-L-HyPip is a component of palinavir, an HIV protease inhibitor (11,12), and cis-5-hydroxy-L-pipecolic acid (cis-5-L-HyPip) is a precursor for the synthesis of the ␤-lactamase inhibitor MK-7655 (13). Thus, the development of processes for the industrial synthesis of HyPips may be of great significance.…”
mentioning
confidence: 99%
“…Compound 4 lacking aminoacids Val and Met from the peptide sequence resulted more soluble, but devoid of enzyme inhibitory activity. basic alumina [14], followed by HATU mediated coupling with dipeptide BocMetValOH gave compound 14.…”
Section: Resultsmentioning
confidence: 99%
“…N-Boc-(2S,4R)-4-hydroxypipecolic tert-butylamide (36) 21,25 was first converted to the (2S,4S)-4-iodo or 4-bromo derivatives (37) via mesylation and displacement with inversion using iodide or bromide. Intermediate 37 was then treated with sulfur nucleophiles to deliver the desired (2S,4R)-4-substituted pipecolic amide derivatives 38a-c through an overall double-inversion process.…”
Section: Resultsmentioning
confidence: 99%
“…After the solution was dried over MgSO4, evaporation of the solvent gave an oil that was purified by flash chromatography using 5% EtOH in CHCl3 as eluent. Preparation of (2S,4R)-4-bromopipecolic tert-butylamide 37 (X ) Br): (2S,4R)-4-hydroxypipecolic tert-butylamide 36 21,25 (70.10 g, 0.233 mol) was dissolved in dry THF (700 mL), and Et3N (42 mL, 0.30 mol) was added. The solution was cooled in an ice-water bath under a nitrogen atmosphere, and methanesulfonyl chloride (22.5 mL, 0.29 mol) was added dropwise over 30 min.…”
Section: Methodsmentioning
confidence: 99%